← Evidence map

ArticleEvidence-based complementary and alternative medicine : eCAM2023

Retracted: Clinical Efficacy of Osimertinib in Patients with Advanced Non-Small Cell Lung Cancer and Its Effect on Serum CEA and VEGF Expression.

Evidence-Based Complementary And Alternative MedicinePubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Full record →Abstract, authors, funding and every citing paper · PMID 38125182